Clinical Trials in Nashville

Showing 16741-16760 of 20,298 trials

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

NCT00463021

Protocol HECT00306 aims to determine clinically appropriate doses of Hectorol (doxercalciferol capsules) when converting from Zemplar (paricalcitol injection) for the treatment of secondary hyperparathyroidism in Stage 5 chronic kidney disease on hemodialysis.

Secondary Hyperparathyroidism

Genzyme, a Sanofi Company36 participantsStarted Apr 2007

Downey, California, United States • Paramount, California, United States • Hudson, Florida, United States +5 more locations

COMPLETEDNA< 1 mile

Nebivolol in the Supine Hypertension of Autonomic Failure

NCT01044693

The purpose of this study is to evaluate the effect of the antihypertensive drug, nebivolol (Bystolic), compared to metoprolol (Lopressor) and sildenafil (Viagra) on blood pressure in patients with autonomic failure and supine hypertension.

HypertensionPure Autonomic FailureMultiple System Atrophy

Vanderbilt University20 participantsStarted Jan 2010

Nashville, Tennessee, United States

COMPLETED< 1 mile

Atrial Fibrillation/Flutter Outcome Risk Determination

NCT01138644

It is our hypotheses that 1) readily available Emergency Department data can be utilized in an Atrial Fibrillation clinical prediction rule to identify those patients at low or high risk for adverse outcomes; 2) Assigned risk can be utilized to drive physician decision-making by identifying patients who do not require hospital admission (low risk) and patients needing hospitalization (high risk); and 3) a facile version of the AFPR will be easily incorporated into standard Emergency Department patient management systems and assist physicians with risk stratification of patients presenting with Atrial Fibrillation.

Atrial FibrillationAtrial Flutter

Vanderbilt University519 participantsStarted Jun 2010

Nashville, Tennessee, United States

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Nebivolol in the Supine Hypertension of Autonomic Failure

Atrial Fibrillation/Flutter Outcome Risk Determination

Find Trials by Condition in Nashville

A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

Lung Screening Study

Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin

LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma

Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer

Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Pegylated Liposomal Doxorubicin, Bortezomib, Dexamethasone and Lenalidomide for Relapsed/Refractory Multiple Myeloma

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)